CRL logo

CRL Net Income

Annual Net Income

$22.20 M
-$452.42 M-95.32%

December 28, 2024

Summary

Performance

1-Year Change

-95.32%

3-Year Change

-94.32%

5-Year Change

-91.19%

15-Year Change

-82%

CRL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.47%
CRL annual net profit is higher than 87.47% of companies in Healthcare sector

High & Low

All-time High

$486.23 M
CRL annual net profit is currently -95.43% below its historical high of $486.23 million

3-Year Low

$22.20 M
CRL annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 28, 2024
CRL previous annual earnings announcement was published on Dec 28, 2024

Next Annual Earnings Report Date

N/A
CRL next annual earnings announcement has not yet been scheduled

OtherCRLprofitabilitymetrics:

Annual Net Margin

0.55%
CRL annual net profit margin is 0.55%

Annual Revenue

$4.05 B
CRL annual revenue is $4.05 billion

Annual Gross Profit

$1.33 B
CRL annual gross profit is $1.33 billion

Annual EPS

$0.20
CRL annual earnings per share is $0.20

Quarterly Net Income

-$213.41 M
-$282.69 M-408.05%

December 28, 2024

Summary

Performance

3-Month Change

-408.05%

1-Year Change

-327.57%

3-Year Change

-327.57%

5-Year Change

-327.57%

CRL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.26%
CRL quarterly net profit is higher than 1.26% of companies in Healthcare sector

High & Low

All-time High

$187.41 M
CRL quarterly net profit is currently -213.88% below its historical high of $187.41 million

3-Year Low

-$213.41 M
CRL quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 28, 2024
CRL previous earnings announcement was published on Dec 28, 2024

Next Quarterly Earnings Report Date

May 9, 2025
CRL next earnings announcement is scheduled for May 9, 2025

OtherCRLprofitabilitymetrics:

Quarterly Net Margin

-21.29%
CRL quarterly net profit margin is -21.29%

Quarterly Revenue

$1.00 B
CRL quarterly revenue is $1.00 billion

Quarterly Gross Profit

$284.24 M
CRL quarterly gross profit is $284.24 million

Quarterly EPS

-$4.22
CRL quarterly earnings per share is -$4.22

TTM Net Income

$22.20 M
-$400.50 M-94.75%

December 28, 2024

Summary

Performance

3-Month Change

-94.75%

1-Year Change

-94.96%

3-Year Change

-94.96%

5-Year Change

-94.96%

CRL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.19%
CRL TTM net profit is higher than 87.19% of companies in Healthcare sector

High & Low

All-time High

$496.33 M
CRL TTM net profit is currently -95.53% below its historical high of $496.33 million

3-Year Low

$22.20 M
CRL TTM net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 28, 2024
CRL previous earnings announcement was published on Dec 28, 2024

Next Quarterly Earnings Report Date

May 9, 2025
CRL next earnings announcement is scheduled for May 9, 2025

OtherCRLprofitabilitymetrics:

Annual Net Margin

0.55%
CRL annual net profit margin is 0.55%

TTM Revenue

$4.05 B
CRL TTM revenue is $4.05 billion

TTM Gross Profit

$1.33 B
CRL TTM gross profit is $1.33 billion

TTM EPS

$0.15
CRL TTM earnings per share is $0.15

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$22.20 M
CRL annual net profit is $22.20 million

Annual Revenue

$4.05 B
CRL annual revenue is $4.05 billion

Annual Cost Of Goods Sold

$2.72 B
CRL annual cost of goods sold is $2.72 billion

Annual Operating Expenses

$889.47 M
CRL annual total operating expenses is $889.47 million

Annual Interest Expense

$126.29 M
CRL annual interest expense is $126.29 million

Annual Income Tax

$67.82 M
CRL annual income tax is $67.82 million

CRL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.3%-327.6%-95.0%
3 y3 years-94.3%-327.6%-95.0%
5 y5 years-91.2%-327.6%-95.0%

CRL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.4%at low-213.9%at low-95.5%at low
5 y5-year-95.4%at low-213.9%at low-95.5%at low
alltimeall time-95.4%+104.3%-213.9%+67.7%-95.5%+103.9%

Charles River Laboratories International Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$22.20 M(-95.3%)
-$213.41 M(-408.1%)
$22.20 M(-94.7%)
Sep 2024
-
$69.28 M(-26.1%)
$422.70 M(-4.1%)
Jun 2024
-
$93.78 M(+29.2%)
$440.81 M(-0.7%)
Mar 2024
-
$72.56 M(-61.2%)
$444.05 M(-6.4%)
Dec 2023
$474.62 M(-2.4%)
$187.08 M(+114.1%)
$474.62 M(-0.1%)
Sep 2023
-
$87.39 M(-9.9%)
$474.95 M(-1.9%)
Jun 2023
-
$97.02 M(-5.9%)
$484.03 M(-2.5%)
Mar 2023
-
$103.13 M(-45.0%)
$496.33 M(+2.1%)
Dec 2022
$486.23 M(+24.4%)
$187.41 M(+94.3%)
$486.23 M(+11.4%)
Sep 2022
-
$96.47 M(-11.8%)
$436.39 M(-1.6%)
Jun 2022
-
$109.32 M(+17.5%)
$443.35 M(+4.9%)
Mar 2022
-
$93.02 M(-32.4%)
$422.47 M(+8.1%)
Dec 2021
$390.98 M(+7.3%)
$137.58 M(+33.0%)
$390.98 M(-1.4%)
Sep 2021
-
$103.43 M(+16.9%)
$396.60 M(+0.1%)
Jun 2021
-
$88.45 M(+43.7%)
$396.08 M(+5.6%)
Mar 2021
-
$61.53 M(-57.0%)
$375.06 M(+3.0%)
Dec 2020
$364.30 M(+44.6%)
$143.19 M(+39.1%)
$364.30 M(+20.8%)
Sep 2020
-
$102.91 M(+52.6%)
$301.46 M(+11.1%)
Jun 2020
-
$67.44 M(+32.8%)
$271.36 M(+9.6%)
Mar 2020
-
$50.77 M(-36.8%)
$247.66 M(-1.7%)
Dec 2019
$252.02 M(+11.3%)
$80.35 M(+10.4%)
$252.02 M(+8.9%)
Sep 2019
-
$72.81 M(+66.5%)
$231.34 M(+5.7%)
Jun 2019
-
$43.73 M(-20.7%)
$218.89 M(-4.4%)
Mar 2019
-
$55.13 M(-7.6%)
$228.88 M(+1.1%)
Dec 2018
$226.37 M(+83.5%)
$59.66 M(-1.2%)
$226.37 M(+65.4%)
Sep 2018
-
$60.37 M(+12.4%)
$136.86 M(+6.1%)
Jun 2018
-
$53.71 M(+2.0%)
$128.97 M(-0.2%)
Mar 2018
-
$52.63 M(-276.3%)
$129.21 M(+4.7%)
Dec 2017
$123.36 M(-20.3%)
-$29.85 M(-156.9%)
$123.36 M(-37.7%)
Sep 2017
-
$52.47 M(-2.7%)
$197.88 M(+8.0%)
Jun 2017
-
$53.95 M(+15.3%)
$183.15 M(+11.4%)
Mar 2017
-
$46.78 M(+4.7%)
$164.40 M(+6.2%)
Dec 2016
$154.76 M(+3.7%)
$44.68 M(+18.4%)
$154.76 M(+9.0%)
Sep 2016
-
$37.73 M(+7.2%)
$141.97 M(+0.3%)
Jun 2016
-
$35.21 M(-5.2%)
$141.61 M(-8.6%)
Mar 2016
-
$37.14 M(+16.5%)
$154.91 M(+3.8%)
Dec 2015
$149.31 M(+17.8%)
$31.88 M(-14.7%)
$149.31 M(+3.3%)
Sep 2015
-
$37.38 M(-22.9%)
$144.59 M(+3.8%)
Jun 2015
-
$48.51 M(+53.8%)
$139.25 M(+10.5%)
Mar 2015
-
$31.54 M(+16.1%)
$126.01 M(-0.5%)
Dec 2014
$126.70 M(+23.2%)
$27.17 M(-15.2%)
$126.70 M(+6.8%)
Sep 2014
-
$32.04 M(-9.2%)
$118.63 M(+1.0%)
Jun 2014
-
$35.26 M(+9.4%)
$117.46 M(+7.3%)
Mar 2014
-
$32.23 M(+68.8%)
$109.48 M(+6.5%)
Dec 2013
$102.83 M(+5.7%)
$19.10 M(-38.1%)
$102.83 M(+0.7%)
Sep 2013
-
$30.87 M(+13.1%)
$102.14 M(+9.5%)
Jun 2013
-
$27.28 M(+6.7%)
$93.25 M(-3.3%)
Mar 2013
-
$25.58 M(+38.9%)
$96.43 M(-0.9%)
Dec 2012
$97.30 M
$18.42 M(-16.2%)
$97.30 M(-8.2%)
Sep 2012
-
$21.97 M(-27.9%)
$105.99 M(+3.1%)
Jun 2012
-
$30.47 M(+15.2%)
$102.82 M(-1.8%)
DateAnnualQuarterlyTTM
Mar 2012
-
$26.44 M(-2.5%)
$104.67 M(-4.5%)
Dec 2011
$109.57 M(-132.5%)
$27.11 M(+44.2%)
$109.57 M(-142.0%)
Sep 2011
-
$18.80 M(-41.8%)
-$261.11 M(-14.3%)
Jun 2011
-
$32.32 M(+3.1%)
-$304.85 M(-5.5%)
Mar 2011
-
$31.34 M(-109.1%)
-$322.72 M(-4.1%)
Dec 2010
-$336.67 M(-394.2%)
-$343.56 M(+1277.5%)
-$336.67 M(-1476.2%)
Sep 2010
-
-$24.94 M(-272.6%)
$24.46 M(-71.8%)
Jun 2010
-
$14.45 M(-16.8%)
$86.72 M(-18.5%)
Mar 2010
-
$17.38 M(-1.1%)
$106.42 M(-7.0%)
Dec 2009
$114.44 M(-121.9%)
$17.57 M(-52.9%)
$114.44 M(-120.3%)
Sep 2009
-
$37.31 M(+9.2%)
-$563.66 M(+1.5%)
Jun 2009
-
$34.15 M(+34.4%)
-$555.49 M(+2.8%)
Mar 2009
-
$25.41 M(-103.8%)
-$540.58 M(+3.6%)
Dec 2008
-$521.84 M(-438.0%)
-$660.54 M(-1552.1%)
-$521.84 M(-397.2%)
Sep 2008
-
$45.49 M(-7.3%)
$175.60 M(+1.6%)
Jun 2008
-
$49.07 M(+11.2%)
$172.89 M(+6.9%)
Mar 2008
-
$44.14 M(+19.6%)
$161.78 M(+4.8%)
Dec 2007
$154.41 M(-376.8%)
$36.91 M(-13.7%)
$154.41 M(+1.1%)
Sep 2007
-
$42.78 M(+12.7%)
$152.69 M(+63.6%)
Jun 2007
-
$37.96 M(+3.2%)
$93.30 M(+15.1%)
Mar 2007
-
$36.76 M(+4.5%)
$81.09 M(-245.4%)
Dec 2006
-$55.78 M(-139.3%)
$35.19 M(-311.9%)
-$55.78 M(+37.6%)
Sep 2006
-
-$16.61 M(-164.5%)
-$40.55 M(-599.1%)
Jun 2006
-
$25.75 M(-125.7%)
$8.13 M(-42.9%)
Mar 2006
-
-$100.11 M(-298.6%)
$14.24 M(-90.0%)
Dec 2005
$142.00 M(+58.1%)
$50.42 M(+57.2%)
$142.00 M(+27.2%)
Sep 2005
-
$32.07 M(+0.7%)
$111.66 M(+5.9%)
Jun 2005
-
$31.86 M(+15.2%)
$105.41 M(+5.6%)
Mar 2005
-
$27.65 M(+37.7%)
$99.85 M(+11.2%)
Dec 2004
$89.79 M(+12.0%)
$20.08 M(-22.2%)
$89.79 M(-0.6%)
Sep 2004
-
$25.82 M(-1.8%)
$90.36 M(+7.4%)
Jun 2004
-
$26.30 M(+49.5%)
$84.13 M(+7.3%)
Mar 2004
-
$17.59 M(-14.8%)
$78.39 M(-2.2%)
Dec 2003
$80.15 M(+59.9%)
$20.64 M(+5.4%)
$80.15 M(+4.1%)
Sep 2003
-
$19.59 M(-4.7%)
$77.01 M(+1.4%)
Jun 2003
-
$20.56 M(+6.2%)
$75.95 M(+5.9%)
Mar 2003
-
$19.35 M(+10.6%)
$71.72 M(+43.1%)
Dec 2002
$50.13 M(+41.6%)
$17.50 M(-5.5%)
$50.13 M(+20.7%)
Sep 2002
-
$18.53 M(+13.5%)
$41.54 M(+23.9%)
Jun 2002
-
$16.33 M(-831.5%)
$33.53 M(+27.9%)
Mar 2002
-
-$2.23 M(-125.0%)
$26.22 M(-25.9%)
Dec 2001
$35.41 M(-415.5%)
$8.92 M(-15.2%)
$35.41 M(+14.5%)
Sep 2001
-
$10.52 M(+16.7%)
$30.92 M(-899.9%)
Jun 2001
-
$9.02 M(+29.7%)
-$3.87 M(-21.3%)
Mar 2001
-
$6.95 M(+57.0%)
-$4.91 M(-56.3%)
Dec 2000
-$11.22 M(-165.5%)
$4.43 M(-118.3%)
-$11.22 M(-28.3%)
Sep 2000
-
-$24.26 M(-404.3%)
-$15.65 M(-281.8%)
Jun 2000
-
$7.97 M(+1153.8%)
$8.61 M(+1253.8%)
Mar 2000
-
$636.00 K
$636.00 K
Dec 1999
$17.12 M(-26.8%)
-
-
Dec 1998
$23.38 M
-
-

FAQ

  • What is Charles River Laboratories International annual net profit?
  • What is the all time high annual net income for Charles River Laboratories International?
  • What is Charles River Laboratories International annual net income year-on-year change?
  • What is Charles River Laboratories International quarterly net profit?
  • What is the all time high quarterly net income for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly net income year-on-year change?
  • What is Charles River Laboratories International TTM net profit?
  • What is the all time high TTM net income for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM net income year-on-year change?

What is Charles River Laboratories International annual net profit?

The current annual net income of CRL is $22.20 M

What is the all time high annual net income for Charles River Laboratories International?

Charles River Laboratories International all-time high annual net profit is $486.23 M

What is Charles River Laboratories International annual net income year-on-year change?

Over the past year, CRL annual net profit has changed by -$452.42 M (-95.32%)

What is Charles River Laboratories International quarterly net profit?

The current quarterly net income of CRL is -$213.41 M

What is the all time high quarterly net income for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly net profit is $187.41 M

What is Charles River Laboratories International quarterly net income year-on-year change?

Over the past year, CRL quarterly net profit has changed by -$307.19 M (-327.57%)

What is Charles River Laboratories International TTM net profit?

The current TTM net income of CRL is $22.20 M

What is the all time high TTM net income for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM net profit is $496.33 M

What is Charles River Laboratories International TTM net income year-on-year change?

Over the past year, CRL TTM net profit has changed by -$418.61 M (-94.96%)